Company registration number 04194817 (England and Wales)
COMPUMEDIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
COMPUMEDIC LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 7
COMPUMEDIC LIMITED
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
1,104
107,687
Current assets
Stocks
2,495
7,257
Debtors
4
98,729
65,981
Cash at bank and in hand
81,883
6,020
183,107
79,258
Creditors: amounts falling due within one year
5
(30,397)
(50,157)
Net current assets
152,710
29,101
Total assets less current liabilities
153,814
136,788
Creditors: amounts falling due after more than one year
6
(16,291)
(22,952)
Provisions for liabilities
(277)
(67)
Net assets
137,246
113,769
Capital and reserves
Called up share capital
2
2
Revaluation reserve
54,213
Capital redemption reserve
2
2
Profit and loss reserves
137,242
59,552
Total equity
137,246
113,769
COMPUMEDIC LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2026
31 March 2026
- 2 -
For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 8 October 2026
Mr G A Moyes
Director
Company registration number 04194817 (England and Wales)
COMPUMEDIC LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
Share capital
Revaluation reserve
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 April 2024
2
55,975
2
41,376
97,355
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
-
34,414
34,414
Dividends
-
-
-
(18,000)
(18,000)
Other movements
-
(1,762)
-
1,762
-
Balance at 31 March 2025
2
54,213
2
59,552
113,769
Year ended 31 March 2026:
Profit and total comprehensive income
-
-
-
41,477
41,477
Dividends
-
-
-
(18,000)
(18,000)
Transfers
-
(54,213)
-
54,213
-
Balance at 31 March 2026
2
2
137,242
137,246
COMPUMEDIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 4 -
1
Accounting policies
Company information
Compumedic Limited is a private company limited by shares incorporated in England and Wales. The registered office is 23 Bryn Glas, Flint, Flintshire, United Kingdom, CH6 5XP.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
2% straight line
Fixtures and fittings
15% reducing balance
Computers
33% straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.6
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
COMPUMEDIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.7
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2026
2025
Number
Number
Total
2
2
3
Tangible fixed assets
Freehold land and buildings
Fixtures and fittings
Computers
Total
£
£
£
£
Cost or valuation
At 1 April 2025
182,203
6,237
586
189,026
Additions
461
771
1,232
Disposals
(182,203)
(182,203)
At 31 March 2026
6,698
1,357
8,055
Depreciation and impairment
At 1 April 2025
74,782
6,001
556
81,339
Depreciation charged in the year
107
287
394
Eliminated in respect of disposals
(74,782)
(74,782)
At 31 March 2026
6,108
843
6,951
COMPUMEDIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
3
Tangible fixed assets
Freehold land and buildings
Fixtures and fittings
Computers
Total
£
£
£
£
(Continued)
- 6 -
Carrying amount
At 31 March 2026
590
514
1,104
At 31 March 2025
107,421
236
30
107,687
Land and buildings with a carrying amount of £107,421 were sold in the year.
The following assets are carried at valuation. If the assets were measured using the cost model, the carrying amounts would be as follows:
Freehold property
2026
2025
£
£
Cost
-
94,099
Accumulated depreciation
-
(40,891)
Carrying value
-
53,208
4
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
60,043
52,235
Other debtors
38,686
13,746
98,729
65,981
5
Creditors: amounts falling due within one year
2026
2025
£
£
Bank loans and overdrafts
5,758
18,551
Trade creditors
3,470
7,336
Corporation tax
8,713
9,278
Other taxation and social security
8,352
9,680
Other creditors
4,104
5,312
30,397
50,157
Creditors include bank loans and overdrafts which are secured of £5,758 ( 2025 - £4,855 ).
COMPUMEDIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 7 -
6
Creditors: amounts falling due after more than one year
2026
2025
£
£
Bank loans and overdrafts
16,291
22,952
Creditors include bank loans which are secured of £16,291 ( 2025 - £22,952 ).